Register entry

Pacira Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
44
Exclusivities
1
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Pacira Pharmaceuticals, Inc.10450 Science Center Dr, San Diego, California (CA) 92121, United States (USA)Analytical testing, Finished drug manufacture3002783962117399934
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
injection, suspension, liposomal2
kit1
RouteNDCs
infiltration2
intra-articular1
Labeller name on the listingNDCs
pacira pharmaceuticals, inc.3
Exclusivity

Patents and exclusivities

44
PatentProductCoversExpiry
8828440ZILRETTAtriamcinolone acetonideproductAug 2031
9555048ZILRETTAtriamcinolone acetonideuseAug 2031
11033495EXPARELbupivacaineproductJan 2041
11179336EXPARELbupivacaineproductJan 2041
11278494EXPARELbupivacaineproductJan 2041
11304904EXPARELbupivacaineproductJan 2041
11311486EXPARELbupivacaineproductJan 2041
11357727EXPARELbupivacaineproductJan 2041
11426348EXPARELbupivacaineproductJan 2041
11452691EXPARELbupivacaineproductJan 2041
11819574EXPARELbupivacaineproductJan 2041
11819575EXPARELbupivacaineproductJan 2041
11925706EXPARELbupivacaineproductJan 2041
12144890EXPARELbupivacaineproductJan 2041
12151024EXPARELbupivacaineproductJan 2041
12296047EXPARELbupivacaineproductJan 2041
11931459EXPARELbupivacaineuseMar 2042
11918565EXPARELbupivacaineuseFeb 2043
12226610EXPARELbupivacaineuseFeb 2043
12156940EXPARELbupivacaineproductJul 2044
12251468EXPARELbupivacaineproductJul 2044
12318483EXPARELbupivacaineuseJul 2044
12370142EXPARELbupivacaineproductJul 2044
ProductExclusivityUntil
EXPARELBUPIVACAINEI-929 New indicationNov 2026
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
EXPARELbupivacaineinjection, suspension, liposomal, infiltration65250-133NDA
EXPARELbupivacaineinjection, suspension, liposomal, infiltration65250-266NDA
Zilrettatriamcinolone acetonide extended-release injectable suspensionkit, intra-articular65250-003NDA
Neighbours

Registered in the same town

12
Compare

Comparable companies in United States

Enquiry

Common questions

Is Pacira Pharmaceuticals, Inc. FDA approved?
Pacira Pharmaceuticals, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Pacira Pharmaceuticals, Inc.'s drugs manufactured?
The FDA register lists San Diego, CA. Registered operations: analytical testing, finished drug manufacture.
What drugs does Pacira Pharmaceuticals, Inc. make?
3 products are listed under Pacira Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, suspension, liposomal; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.